PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook

BACKGROUND: Prostate specific membrane antigen (PSMA) PET imaging has recently gained attention in glioblastoma (GBM) patients as a potential theranostic target for PSMA radioligand therapy. However, PSMA PET has not yet been established in a murine GBM model. Our goal was to investigate the potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirchner, Maximilian A., Holzgreve, Adrien, Brendel, Matthias, Orth, Michael, Ruf, Viktoria C., Steiger, Katja, Pötter, Dennis, Gold, Lukas, Unterrainer, Marcus, Mittlmeier, Lena M., Barci, Enio, Kälin, Roland E., Glass, Rainer, Lindner, Simon, Kaiser, Lena, Maas, Jessica, von Baumgarten, Louisa, Ilhan, Harun, Belka, Claus, Notni, Johannes, Bartenstein, Peter, Lauber, Kirsten, Albert, Nathalie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635528/
https://www.ncbi.nlm.nih.gov/pubmed/34869017
http://dx.doi.org/10.3389/fonc.2021.774017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635528/
https://www.ncbi.nlm.nih.gov/pubmed/34869017
http://dx.doi.org/10.3389/fonc.2021.774017

Ejemplares similares